For proteins to function properly, they must take on the right shape. Misfolded proteins are the root of many diseases. Congruence Therapeutics is using computational tools to discover and develop ...
Congruence pulls in $50M series A to build a team of 'drug hunters' to go after rare disease targets
A new biotech called Congruence Therapeutics snagged $50 million to build a new team of "drug hunters" focused on protein misfolding to go after rare diseases. Congruence Therapeutics just completed a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results